New pill trial offers hope for stiff, painful spine condition
NCT ID NCT07172360
Summary
This large, late-stage study is testing whether a new tablet called VC005 can help control the painful inflammation and stiffness of active ankylosing spondylitis. It will involve 420 adults with the condition to see if the drug safely improves their symptoms. The main goal is to see how many people feel at least 20% better after 12 weeks of treatment compared to a control group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTIVE ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.